GE HealthCare Technologies (GEHC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
19 Mar, 2026Voting matters and shareholder proposals
Shareholders are asked to elect eight directors, with each nominee recommended by the board for election.
An advisory vote is being held to approve named executive officers' compensation.
Ratification of Deloitte & Touche LLP as the independent auditor for the fiscal year ending December 31, 2026, is on the agenda.
Board of directors and corporate governance
Eight director nominees are presented for election, including Peter J. Arduini, H. Lawrence Culp, Jr., Rodney F. Hochman, Catherine Lesjak, Kevin A. Lobo, Anne T. Madden, William J. Stromberg, and Phoebe L. Yang.
Executive compensation and say-on-pay
Shareholders are invited to cast an advisory vote on the compensation of named executive officers.
Partial view of Summaries dataset, powered by Quartr API
Latest events from GE HealthCare Technologies
- Board seeks approval for director slate, executive pay, and auditor, highlighting governance and ESG.GEHC
Proxy filing19 Mar 2026 - Record backlog and new product launches underpin 3%-4% growth, with major innovations ahead.GEHC
Barclays 28th Annual Global Healthcare Conference13 Mar 2026 - Innovation and digital growth drive 2026 outlook, with new products fueling future gains.GEHC
Citi’s 2026 Unplugged MedTech and Life Sciences Access Day26 Feb 2026 - Strong 2025 results, record backlog, and 2026 growth guided at 3%-4% with margin expansion.GEHC
Q4 20254 Feb 2026 - Margin expansion and innovation in diagnostics drive strong outlook and future growth.GEHC
51st Nasdaq London Investor Conference3 Feb 2026 - Q2 margin gains and U.S. strength offset China headwinds, but growth outlook was cut.GEHC
Q2 20242 Feb 2026 - Innovation, margin expansion, and disciplined pricing set the stage for accelerated growth.GEHC
Jefferies Global Healthcare Conference1 Feb 2026 - Margin expansion, innovation, and AI drive growth amid China volatility and strong PDX performance.GEHC
2024 Wells Fargo Healthcare Conference22 Jan 2026 - AI, radiopharma, and SaaS are fueling growth, margin gains, and service expansion.GEHC
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026